Crescent Biopharma, Inc. aksje
CBIO
After-hours$19.72-0.93 (-4.50%)
Post-Market:$19.720.00 (0.00%)
Laster graf...
Crescent Biopharma, Inc.
Market Cap
$543,775,488
Åpning19.17
Høy20.43
Lav18.89
Volum423.41k
P/EN/A
Markedsverdi543.78M
52-ukers høy27.41
52-ukers lav8.72
Gj.sn. volum264.6k
UtbytteN/A
BetaN/A
EPS-5.88
Om Crescent Biopharma, Inc. aksje
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.
Selskapsinformasjon
Børs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
300 Fifth Avenue
02451 Waltham, United States
02451 Waltham, United States
Telefon: + 617 460 5595
Nettside: https://crescentbiopharma.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.11 - Stærk køb
Laveste kursmål
27.00
↑ 36.9%
Gjennomsnittlig kursmål
31.67
↑ 60.6%
Median kursmål
32.50
↑ 64.8%
Høyeste kursmål
35.00
↑ 77.5%